Beside commercial products the pipeline contains both partner projects and in-house development projects. Our aim and ambition is to create value through development and commercialization of new drugs offering superior medical benefit addressing unmet medical needs. During 2016, several important steps were taken to develop next generation drug delivery technologies. Technologies for a novel oral formulation, as well as the second generation sublingual formulation, are currently being explored.